Cabozantinib to Treat Resistant Form of Thyroid Cancer
Radioactive iodine therapy is the standardized treatment for thyroid cancer but nearly 15 percent of these patients have cancers that are resistant to the therapy. Cabozantinib drug could be a new firstline therapy for metastatic, radioactive iodine-resistant thyroid cancer.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer